Difference between revisions of "Team:SCUT-China/Practices"
| Line 82: | Line 82: | ||
<div id="HPContent"> | <div id="HPContent"> | ||
<div class="part"> | <div class="part"> | ||
| − | <h3 style="color:# | + | <h3 style="color:#d53f60">Overview</h3> |
<p>According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line. We hope that our work would provide the proof of principle for future gene therapy.</p> | <p>According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line. We hope that our work would provide the proof of principle for future gene therapy.</p> | ||
| Line 89: | Line 89: | ||
<div class="part"> | <div class="part"> | ||
<div class="pic_four"> | <div class="pic_four"> | ||
| − | <div class="pic_a"><img src=" | + | <div class="pic_a"><img src="https://static.igem.org/mediawiki/2015/4/4d/2015-SCUT-China-practice-interview.png" /><a class="page-link" href="https://2015.igem.org/Team:SCUT-China/hospitalInterview">Hospital Interview</a></div> |
| − | <div class="pic_b"><img src=" | + | <div class="pic_b"><img src="https://static.igem.org/mediawiki/2015/1/12/2015-SCUT-China-practice-conference.png" /><a class="page-link" href="https://2015.igem.org/Team:SCUT-China/Conference">Conference</a></div> |
| − | <div class="pic_c"><img src=" | + | <div class="pic_c"><img src="https://static.igem.org/mediawiki/2015/2/23/2015-SCUT-China-practice-dataAnalyse.png" /><a class="page-link" href="https://2015.igem.org/Team:SCUT-China/dataAnalyse">data analyse</a></div> |
| − | <div class="pic_d"><img src=" | + | <div class="pic_d"><img src="https://static.igem.org/mediawiki/2015/0/0f/2015-SCUT-China-practice-thinking.png" /><a class="page-link" href="https://2015.igem.org/Team:SCUT-China/criticalThinking">thinking</a></div> |
</div> | </div> | ||
</div> | </div> | ||
<div class="part"> | <div class="part"> | ||
| − | <img class="mind-pic" src=" | + | <img class="mind-pic" src="https://2015.igem.org/File:2015-SCUT-China-practice-mind.png"/> |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 12:58, 18 September 2015
Loading
Human Practices
Overview
According to the data from WHO, cardiovascular diseases are the main leading cause of death globally. Cyclic guanosine monophosphate (cGMP) is a critical second messenger molecule.It can transduce nitric-oxide and natriuretic-peptide-coupled signaling and remit the myocardial hypertrophy by relaxing the blood vessels. This summer, we tried to use synthetic biology to modify the cGMP metabolic pathway in a human cell line. We hope that our work would provide the proof of principle for future gene therapy.
